Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $134.4900 (-0.75%) ($134.0600 - $136.0900) on Mon. Jul. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.47% (three month average) | RSI | 36 | Latest Price | $134.4900(-0.75%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(53%) SPLV(44%) DIA(39%) VYM(37%) XLP(36%) | Factors Impacting ABBV price | ABBV will decline at least -0.735% in a week (0% probabilities). VXX(-20%) VIXM(-19%) SLV(-18%) GDXJ(-18%) GDX(-17%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.735% (StdDev 1.47%) | Hourly BBV | -1.6 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $135.98 | 5 Day Moving Average | $135.97(-1.09%) | 10 Day Moving Average | $134.85(-0.27%) | 20 Day Moving Average | $135.98(-1.1%) | To recent high | -18.4% | To recent low | 1.5% | Market Cap | $237.278b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |